Clinical Trial Update: Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

View source ↗

Summary

A completed clinical trial (IRIS-PRIME) evaluating the effectiveness and safety of the XIENCE PRIME drug-eluting stent for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Xience Prime Stent (everolimus-eluting stent)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Status: COMPLETED